CIK 0001689375
- Accelerated filer
- Smaller reporting company
- Emerging growth company
Entrada Therapeutics, Inc.
Sign in to watch- Ticker
- TRDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813983399
- Phone
- +1 857-305-1825
- Business address
- ONE DESIGN CENTER PLACE, SUITE 17-500, BOSTON, MA, 02210
- Former names
- CycloPorters, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,200,939
- in 8 filings
Net −$7,200,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 21 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-02 | WENTWORTH KORY JAMES Chief Financial Officer | Shares withheld for taxes | −1,733 | $7.14 | $12K | 117,277 |
| 2026-04-01 | WENTWORTH KORY JAMES Chief Financial Officer | Sale 10b5-1 | −2,500 | $12.95 | $32K | 119,010 |
| 2026-03-10 | WENTWORTH KORY JAMES Chief Financial Officer | Sale 10b5-1 | −11,388 | $13.02 | $148K | 121,510 |
| 2026-03-09 | WENTWORTH KORY JAMES Chief Financial Officer | Sale 10b5-1 | −5,089 | $13.00 | $66K | 132,898 |
| 2026-03-04 | WENTWORTH KORY JAMES Chief Financial Officer | Sale 10b5-1 | −7,988 | $12.25 | $98K | 137,987 |
| 2026-03-03 | WENTWORTH KORY JAMES Chief Financial Officer | Shares withheld for taxes | −5,712 | $11.76 | $67K | 145,975 |
| 2026-03-02 | WENTWORTH KORY JAMES Chief Financial Officer | Shares withheld for taxes | −2,939 | $11.66 | $34K | 151,687 |
| 2026-03-01 | WENTWORTH KORY JAMES Chief Financial Officer | Grant or award | +44,600 | 154,626 | ||
| 2026-03-01 | WENTWORTH KORY JAMES Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +66,600 | 66,600 | ||
| 2025-11-21 | WENTWORTH KORY JAMES Chief Financial Officer | Sale 10b5-1 | −8,910 | $9.98 | $89K | 110,026 |
| 2025-09-02 | WENTWORTH KORY JAMES Chief Financial Officer | Shares withheld for taxes | −1,734 | $5.43 | $9K | 118,936 |
| 2025-04-03 | WENTWORTH KORY JAMES Chief Financial Officer | Exercise or conversion | +11,134 | $2.10 | $23K | 120,670 |
| 2025-04-03 | WENTWORTH KORY JAMES Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) | −11,134 | 20,023 | ||
| 2025-03-17 | WENTWORTH KORY JAMES Chief Financial Officer | Sale 10b5-1 | −1,784 | $10.67 | $19K | 109,536 |
| 2025-03-03 | WENTWORTH KORY JAMES Chief Financial Officer | Shares withheld for taxes | −4,929 | $11.68 | $58K | 111,320 |
| 2025-03-01 | WENTWORTH KORY JAMES Chief Financial Officer | Grant or award | +42,400 | 116,249 | ||
| 2025-03-01 | WENTWORTH KORY JAMES Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +63,300 | 63,300 | ||
| 2024-12-02 | WENTWORTH KORY JAMES Chief Financial Officer | Exercise or conversion 10b5-1 | +5,000 | $2.10 | $11K | 78,849 |
| 2024-12-02 | WENTWORTH KORY JAMES Chief Financial Officer | Sale 10b5-1 | −5,000 | $20.00 | $100K | 73,849 |
| 2024-12-02 | WENTWORTH KORY JAMES Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −5,000 | 31,157 |
Page 1 of 6 · 114 trades